TY  - JOUR
AU  - Garcia-Menendez, Estefanya
AU  - Marques Vidas, Maria
AU  - Alique, Matilde
AU  - Carracedo, Julia
AU  - de Sequera, Patricia
AU  - Corchete, Elena
AU  - Perez Garcia, Rafael
AU  - Ramirez Chamond, Rafael
AU  - Portoles Perez, Jose M
PY  - 2018
DO  - 10.1016/j.nefro.2018.11.001
UR  - http://hdl.handle.net/10668/13532
T2  - Nefrologia
AB  - Patients with chronic kidney disease (CKD) have higher risk of developing cardiovascular disease. In CKD patients the mechanisms involved in, endothelial damage and the role of different drugs used on these patients are not completely understood. The...
AB  - Antecedentes y objetivos: Los pacientes con insuficiencia renal crónica (IRC) corren mayor riesgo de desarrollar enfermedad cardiovascular. En los pacientes con IRC, los mecanismos implicados en la disfunción endotelial y el papel de los diferentes...
LA  - es
PB  - Elsevier
KW  - Antiagregantes plaquetarios
KW  - Antiplatelet agents
KW  - Chronic kidney disease
KW  - Disfunción endotelial
KW  - Endothelial dysfunction
KW  - Endothelial microvesicles
KW  - Estatinas
KW  - Insuficiencia renal crónica
KW  - Microvesículas endoteliales
KW  - Statins
KW  - Adult
KW  - Advanced oxidation protein products
KW  - Aged
KW  - Biomarkers
KW  - Cell-derived microparticles
KW  - Cross-sectional studies
KW  - Endothelium, vascular
KW  - Female
KW  - Humans
KW  - Hydroxymethylglutaryl-CoA reductase inhibitors
KW  - Male
KW  - Middle aged
KW  - Platelet aggregation inhibitors
KW  - Renal insufficiency, chronic
KW  - Vascular endothelial growth factor A
TI  - El uso de estatinas y antiagregantes se asocia con cambios en los marcadores de disfunción endotelial en la enfermedad renal crónica.
T2  - Statins and antiplatelet agents are associated with changes in the circulatory markers of endothelial dysfunction in chronic kidney disease.
TY  - Research article
VL  - 39
ER  -